REFERENCES
2. Minamino T, Yoshida T, Tateno K, et al. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation. 2003;108:2264-9.
4. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-41.
5. Perler BK, Friedman ES, Wu GD. The role of the gut microbiota in the relationship between diet and human health. Annu Rev Physiol. 2023;85:449-68.
6. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11:577-91.
7. Yang F, Chen H, Gao Y, et al. Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment. Biomed Pharmacother. 2020;130:110503.
8. O’donnell JA, Zheng T, Meric G, Marques FZ. The gut microbiome and hypertension. Nat Rev Nephrol. 2023;19:153-67.
9. Liu T, Sun Z, Yang Z, Qiao X. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: focused on host defense peptides. Biomed Pharmacother. 2023;162:114586.
10. Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022;81:101706.
11. Verhaar BJ, Wijdeveld M, Wortelboer K, et al. Effects of oral butyrate on blood pressure in patients with hypertension: a randomized, placebo-controlled trial. Hypertension. 2024;81:2124-36.
12. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346-54.
13. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139-46.
14. Faleeva M, Ahmad S, Theofilatos K, et al. Sox9 accelerates vascular aging by regulating extracellular matrix composition and stiffness. Circ Res. 2024;134:307-24.
15. Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849-67.
16. Ji Y, Peng X, Chen S, Song Q, Bai J, Cai J. Evening home pulse pressure predicted cardiovascular events and mortality in older adults with hypertension: findings based on the STEP trial. Hypertens Res. 2025;48:2801-10.
17. Pucci G, Spronck B, Avolio AP, et al. Age-specific acute changes in carotid-femoral pulse wave velocity with head-up tilt. Am J Hypertens. 2020;33:1112-8.
18. Tsimploulis A, Sheriff HM, Lam PH, et al. Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: insights from the Cardiovascular Health Study. Int J Cardiol. 2017;235:11-6.
19. Saeedi Saravi SS, Pugin B, Constancias F, et al. Gut microbiota-dependent increase in phenylacetic acid induces endothelial cell senescence during aging. Nat Aging. 2025;5:1025-45.
20. Gan L, Liu D, Liu J, et al. CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. Sig Transduct Target Ther. 2021;6:223.
21. Liu S, He Y, Zhang Y, et al. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms. Gut Microbes. 2023;15:2290331.
22. Xu J, Moore BN, Pluznick JL. Short-chain fatty acid receptors and blood pressure regulation: council on hypertension mid-career award for research excellence 2021. Hypertension. 2022;79:2127-37.
23. Tang WW, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120:1183-96.
24. Zhang D, Jian Y, Zhang Y, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21:212.
25. Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice. Circulation. 2001;103:448-54.
26. Yin L, Bai J, Yu W, Liu Y, Li H, Lin Q. Blocking VCAM-1 prevents angiotensin II-induced hypertension and vascular remodeling in mice. Front Pharmacol. 2022;13:825459.
27. Trejo-Moreno C, Jiménez-Ferrer E, Castro-Martínez G, et al. Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II. Sci Rep. 2021;11:21193.
28. Zhang W, Zhang S, Yan P, et al. A single-cell transcriptomic landscape of primate arterial aging. Nat Commun. 2020;11:2202.
29. Pang J, Pan L, Shen W, et al. Endothelial LRRC8A delays vascular ageing in natural and accelerated ageing mouse models. Cardiovasc Res. 2025;121:2549-64.
30. Muralitharan RR, Nakai ME, Snelson M, et al. Influence of angiotensin II on the gut microbiome: modest effects in comparison to experimental factors. Cardiovasc Res. 2024;120:1155-63.
31. Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in health and disease. Physiol Rev. 2020;100:171-210.
32. Brown AJ, Goldsworthy SM, Barnes AA, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312-9.
33. Pham QH, Bui TVA, Sim W, et al. Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease. Cardiovasc Res. 2024;120:1737-51.
34. Bellet MM, Curcio F, Frati L, Pariano M, Romani L, Corsi-Romanelli MM. The gut microbiome as a possible mediator in autoimmunity and cardiovascular disease: shared pathways and therapeutic implications. Am J Pathol. 2025;195:2288-302.
35. Fitzgerald BG, Govind M, Firth IJ, et al. Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids. Microbiome. 2025;13:201.
36. Wei G, Liu W, Shen F, et al. Polystyrene microplastics exposure increases the disruption of intestinal barrier integrity and gut microbiota homeostasis during obesity and aging. J Environ Sci. 2026;162:430-43.
37. Melgarejo JD, Thijs L, Wei D, et al. Relative and absolute risk to guide the management of pulse pressure, an age-related cardiovascular risk factor. Am J Hypertens. 2021;34:929-38.
38. Safar ME. Arterial aging—hemodynamic changes and therapeutic options. Nat Rev Cardiol. 2010;7:442-9.
39. Wang H, Martinez Yus M, Brady T, et al. Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice. Am J Physiol Heart Circ Physiol. 2024;327:H642-59.
